The U.S. Center for Disease Control conducted whole-genome sequencing of a Candida auris isolate from Iran and 74 isolates from other countries and confirmed that the isolate from Iran was genetically distinct from the 4 existing clades. This has resulted in a new clade of Candida auris being identified.
Candida auris has been found on hospital mattresses, furniture, sinks, and medical equipment. In a new study, researchers wanted to determine how the fungus gets onto those surfaces.
The requirements, for hospitals and nursing homes, could include mandatory pre-admission screening of patients believed to be at-risk and placing in isolation those patients who are infected or carrying Candida auris.
Research demonstrated that procedures used to contain Candida auris infection in an animal facility can potentially be applied to hospitals and other healthcare facilities to limit its spread.
Canadian doctors are being warned about the appearance of Candida auris after 19 cases were identified in the country so far.
Biotechnology company Scynexis, Inc., is reporting early but promising results from a phase 3 trial of a novel drug for treating invasive Candida auris infections.
The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs.
Superbug infections kill 700 people each year in Hong Kong’s public hospitals, fuelled by overuse of antibiotics in healthcare and farming sectors.
Candida auris has developed the ability to survive on cool external skin and cold inorganic surfaces, allowing it to linger on the hands of healthcare workers and on the doorknobs and counters and computer keys of a hospital room. It can travel from its original host to new victims, passing from person to person in outbreaks that last for weeks or months.
Outbreaks of the fungal pathogen Candida auris in healthcare settings may be linked to multi-use patient equipment, such as thermometers, according to new research.